▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3085 by analyst upside · 2026-08-13
COAG
Hemab Therapeutics Holdings, Inc.
Healthcare · Market Cap $2B · P/E 0x
ANALYST PRICE TARGET
+10.3%
implied upside to consensus target
Current Price $53.48
Consensus Target $59.0
Bull Target $65.0
Bear Target $47.0
Analysts Covering 5
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
5
Hold
0
Sell
0
52-Week Low $23.0
52-Week High $54.66
YTD Return +57.3%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-10.41
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $23.0
52-Week High $54.66
Current Price $53.48
Bear Target $47.0
Bull Target $65.0
● Now $53.48 ● Target $59.0
TRADING DATA
Avg Volume 322K
YTD Return +57.3%
Analyst Count 5
Consensus Buy
Upside to Target +10.3%
Last Updated 2026-08-13

ANALYST SUMMARY

Hemab Therapeutics Holdings, Inc. (COAG) is currently trading at $53.48 with a Wall Street consensus price target of $59.0, implying potential upside of 10.3% over the next 12 months. 5 analysts currently cover COAG, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $65.0, while the most cautious has a target of $47.0.

COAG operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 57.3% year-to-date and is currently trading near the upper end of its 52-week range of $23.0 – $54.66.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

HRMY +15.9%
Harmony Biosciences Holdings, Inc.
$2B · P/E 12.9x · Buy
AUPH +10.0%
Aurinia Pharmaceuticals Inc.
$2B · P/E 6.7x · Buy
MD -1.3%
Pediatrix Medical Group, Inc.
$2B · P/E 12.7x · Hold
AVAH +15.5%
Aveanna Healthcare Holdings Inc.
$2B · P/E 7.5x · Buy
ADUS +14.1%
Addus HomeCare Corporation
$2B · P/E 20.5x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for COAG, with each firm's 90-day track record across all stocks we track. See full firm rankings →

HC Wainwright & Co. ● Initiated
Buy 2026-06-17 31% win rate (48 calls)
Wedbush ● Initiated
Outperform 2026-05-26 Building track record
Jefferies ● Initiated
Buy 2026-05-26 50% win rate (6 calls)
Evercore ISI Group ● Initiated
Outperform 2026-05-26 Building track record
Goldman Sachs ● Initiated
Buy 2026-05-26 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
64
out of 100
Coverage depth
14/30
Consensus clarity
23/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →